Adamis completes direct public offering

Adamis Pharmaceuticals Corp. (NASDAQ:ADMP), San Diego, Calif. Business: Inflammation, Cancer, Endocrine/Metabolic Date completed: 2016-07-29 Type: Direct public offering Raised: $11.1 million Units: 3...